{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:23:48Z","timestamp":1794507828127,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100015138","name":"Marriott Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015138","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bipolar disorder (BD) is highly heterogeneous in symptomatology. Narrowing the clinical phenotype may increase the power to identify risk genes that contribute to particular BD subtypes. This study was designed to test the hypothesis that genetic overlap between schizophrenia (SZ) and BD is higher for BD with a history of manic psychosis. Analyses were conducted using a Mayo Clinic Bipolar Biobank cohort of 957 bipolar cases (including 333 with history of psychosis during mania, 64 with history of psychosis only during depression, 547 with no history of psychosis, and 13 with unknown history of psychosis) and 778 controls. Polygenic risk score (PRS) analysis was performed by calculating a SZ-PRS for the BD cases and controls, and comparing the calculated SZ risk between different psychosis subgroups and bipolar types. The SZ-PRS was significantly higher for BD-I cases with manic psychosis than BD-I cases with depressive psychosis (Nagelkerke\u2019s <jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.021; <jats:italic>p<\/jats:italic>\u2009=\u20090.045), BD-I cases without psychosis (<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.015; <jats:italic>p<\/jats:italic>\u2009=\u20090.007), BD-II cases without psychosis (<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.014; <jats:italic>p<\/jats:italic>\u2009=\u20090.017), and controls (<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20090.065; <jats:italic>p<\/jats:italic>\u2009=\u20092\u2009\u00d7\u200910<jats:sup>\u221213<\/jats:sup>). No other significant differences were found. Our results show that BD-I with manic psychosis is genetically more similar to SZ than any other tested BD subgroup. Further investigations on genetics of distinct clinical phenotypes composing major psychoses may help refine the current diagnostic classification system.<\/jats:p>","DOI":"10.1038\/s41398-018-0242-3","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T11:29:36Z","timestamp":1536578976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Association of schizophrenia polygenic risk score with manic and depressive psychosis in bipolar disorder"],"prefix":"10.1038","volume":"8","author":[{"given":"Matej","family":"Markota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon J.","family":"Coombes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth R.","family":"Larrabee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marin","family":"Veldic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Colby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo B.","family":"Cuellar-Barboza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel L.","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa A.","family":"Rummans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William V.","family":"Bobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9350-4440","authenticated-orcid":false,"given":"Joanna M.","family":"Biernacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"issue":"Suppl. 2","key":"242_CR1","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.euroneuro.2004.03.006","volume":"14","author":"M Alda","year":"2004","unstructured":"Alda, M. The phenotypic spectra of bipolar disorder. Eur. Neuropsychopharmacol. 14(Suppl. 2), S94\u2013S99 (2004).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"242_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/07853890802409489","volume":"41","author":"M Alda","year":"2009","unstructured":"Alda, M., Hajek, T., Calkin, C. & O'Donovan, C. Treatment of bipolar disorder: new perspectives. Ann. Med. 41, 186\u2013196 (2009).","journal-title":"Ann. Med."},{"key":"242_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jad.2014.04.026","volume":"165","author":"SJ Winham","year":"2014","unstructured":"Winham, S. J. et al. Bipolar disorder with comorbid binge eating history: a genome-wide association study implicates APOB. J. Affect Disord. 165, 151\u2013158 (2014).","journal-title":"J. Affect Disord."},{"key":"242_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ajmg.b.30558","volume":"147B","author":"EH Saunders","year":"2008","unstructured":"Saunders, E. H., Scott, L. J., McInnis, M. G. & Burmeister, M. Familiality and diagnostic patterns of subphenotypes in the National Institutes of Mental Health bipolar sample. Am. J. Med. Genet. B 147B, 18\u201326 (2008).","journal-title":"Am. J. Med. Genet. B"},{"key":"242_CR5","unstructured":"Kraepelin, E., Barclay, R. M. & Robertson, G. M. Manic-Depressive Insanity and Paranoia. Ayer Co. Pub: Salem, NH, 1990."},{"key":"242_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.biopsych.2012.07.031","volume":"73","author":"A Anticevic","year":"2013","unstructured":"Anticevic, A. et al. Global prefrontal and fronto-amygdala dysconnectivity in bipolar I disorder with psychosis history. Biol. Psychiatry 73, 565\u2013573 (2013).","journal-title":"Biol. Psychiatry"},{"key":"242_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.128","volume":"5","author":"H Pantazopoulos","year":"2015","unstructured":"Pantazopoulos, H. et al. Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: a postmortem study on the amygdala. Transl. Psychiatry 5, e496 (2015).","journal-title":"Transl. Psychiatry"},{"key":"242_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1176\/appi.ajp.2015.14091200","volume":"173","author":"BA Clementz","year":"2016","unstructured":"Clementz, B. A. et al. Identification of distinct psychosis biotypes using brain-based biomarkers. Am. J. Psychiatry 173, 373\u2013384 (2016).","journal-title":"Am. J. Psychiatry"},{"key":"242_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.biopsych.2016.08.030","volume":"82","author":"EI Ivleva","year":"2017","unstructured":"Ivleva, E. I. et al. Brain structure biomarkers in the psychosis biotypes: findings from the bipolar\u2013schizophrenia network for intermediate phenotypes. Biol. Psychiatry 82, 26\u201339 (2017).","journal-title":"Biol. Psychiatry"},{"key":"242_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.biopsych.2016.04.006","volume":"81","author":"H Pantazopoulos","year":"2017","unstructured":"Pantazopoulos, H., Wiseman, J. T., Markota, M., Ehrenfeld, L. & Berretta, S. Decreased numbers of somatostatin-expressing neurons in the amygdala of subjects with bipolar disorder or schizophrenia: relationship to circadian rhythms. Biol. Psychiatry 81, 536\u2013547 (2017).","journal-title":"Biol. Psychiatry"},{"key":"242_CR11","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/S0140-6736(12)62129-1","volume":"381","author":"Cross-Disorder Group of the Psychiatric Genomics C.","year":"2013","unstructured":"Cross-Disorder Group of the Psychiatric Genomics C. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371\u20131379 (2013).","journal-title":"Lancet"},{"key":"242_CR12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","volume":"460","author":"C International Schizophrenia","year":"2009","unstructured":"International Schizophrenia, C. et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748\u2013752 (2009).","journal-title":"Nature"},{"key":"242_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature12975","volume":"506","author":"SM Purcell","year":"2014","unstructured":"Purcell, S. M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185\u2013190 (2014).","journal-title":"Nature"},{"key":"242_CR14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/schbul\/sbp020","volume":"35","author":"N Craddock","year":"2009","unstructured":"Craddock, N., O'Donovan, M. C. & Owen, M. J. Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or \"schizoaffective\") psychoses. Schizophr. Bull. 35, 482\u2013490 (2009).","journal-title":"Schizophr. Bull."},{"key":"242_CR15","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/mp.2009.49","volume":"15","author":"EK Green","year":"2010","unstructured":"Green, E. K. et al. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol. Psychiatry 15, 1016\u20131022 (2010).","journal-title":"Mol. Psychiatry"},{"key":"242_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0140-6736(09)60072-6","volume":"373","author":"P Lichtenstein","year":"2009","unstructured":"Lichtenstein, P. et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373, 234\u2013239 (2009).","journal-title":"Lancet"},{"key":"242_CR17","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/ng.201","volume":"40","author":"MC O'Donovan","year":"2008","unstructured":"O'Donovan, M. C. et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat. Genet. 40, 1053\u20131055 (2008).","journal-title":"Nat. Genet."},{"key":"242_CR18","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/mp.2013.138","volume":"19","author":"DM Ruderfer","year":"2014","unstructured":"Ruderfer, D. M., Fanous, A. H., Ripke, S., McQuillin, A. & Amdur, R. L., Schizophrenia Working Group of the Psychiatric Genomics C. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol. Psychiatry 19, 1017\u20131024 (2014).","journal-title":"Mol. Psychiatry"},{"key":"242_CR19","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.cell.2018.05.046","volume":"173","author":"D Ruderfer","year":"2018","unstructured":"Ruderfer, D., Sklar, P. & Kendler, K. Genomic dissection of bipolar disorder and schizophrenia including 28 subphenotypes. Cell. 173, 1705\u20131715 (2018).","journal-title":"Cell."},{"key":"242_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1192\/bjp.bp.110.087866","volume":"198","author":"ML Hamshere","year":"2011","unstructured":"Hamshere, M. L. et al. Polygenic dissection of the bipolar phenotype. Br. J. Psychiatry 198, 284\u2013288 (2011).","journal-title":"Br. J. Psychiatry"},{"key":"242_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1001\/jamapsychiatry.2017.3485","volume":"75","author":"J Allardyce","year":"2018","unstructured":"Allardyce, J. et al. Association between schizophrenia-related polygenic liability and the occurrence and level of mood-incongruent psychotic symptoms in bipolar disorder. JAMA Psychiatry 75, 28\u201335 (2018).","journal-title":"JAMA Psychiatry"},{"key":"242_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/mp.2013.173","volume":"19","author":"IB Hickie","year":"2014","unstructured":"Hickie, I. B. Evidence for separate inheritance of mania and depression challenges current concepts of bipolar mood disorder. Mol. Psychiatry 19, 153\u2013155 (2014).","journal-title":"Mol. Psychiatry"},{"key":"242_CR23","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/archgenpsychiatry.2012.38","volume":"69","author":"KR Merikangas","year":"2012","unstructured":"Merikangas, K. R. et al. Mania with and without depression in a community sample of US adolescents. Arch. Gen. Psychiatry 69, 943\u2013951 (2012).","journal-title":"Arch. Gen. Psychiatry"},{"key":"242_CR24","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1176\/appi.ajp.160.12.2099","volume":"160","author":"M Tohen","year":"2003","unstructured":"Tohen, M. et al. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Am. J. Psychiatry 160, 2099\u20132107 (2003).","journal-title":"Am. J. Psychiatry"},{"key":"242_CR25","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4088\/JCP.v69n0209","volume":"69","author":"A Martinez-Aran","year":"2008","unstructured":"Martinez-Aran, A. et al. Neurocognitive impairment in bipolar patients with and without history of psychosis. J. Clin. Psychiatry 69, 233\u2013239 (2008).","journal-title":"J. Clin. Psychiatry"},{"key":"242_CR26","volume":"3","author":"MA Frye","year":"2015","unstructured":"Frye, M. A. et al. Development of a bipolar disorder biobank: differential phenotyping for subsequent biomarker analyses. Int. J. Bipolar Disord. 3, 30 (2015).","journal-title":"Int. J. Bipolar Disord."},{"key":"242_CR27","unstructured":"American Psychiatric Association. Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR 4th edn, xxxvii, 943 (American Psychiatric Association, Washington, DC, 2000)."},{"key":"242_CR28","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.mayocp.2013.06.006","volume":"88","author":"JE Olson","year":"2013","unstructured":"Olson, J. E. et al. The Mayo Clinic Biobank: a building block for individualized medicine. Mayo Clin. Proc. 88, 952\u2013962 (2013).","journal-title":"Mayo Clin. Proc."},{"key":"242_CR29","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ng.2354","volume":"44","author":"B Howie","year":"2012","unstructured":"Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955\u2013959 (2012).","journal-title":"Nat. Genet."},{"key":"242_CR30","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/bioinformatics\/btu848","volume":"31","author":"J Euesden","year":"2015","unstructured":"Euesden, J., Lewis, C. M. & O'Reilly, P. F. PRSice: Polygenic Risk Score software. Bioinformatics 31, 1466\u20131468 (2015).","journal-title":"Bioinformatics"},{"key":"242_CR31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics C.","year":"2014","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421\u2013427 (2014).","journal-title":"Nature"},{"key":"242_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).","journal-title":"Gigascience"},{"key":"242_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.242","volume":"7","author":"AW Charney","year":"2017","unstructured":"Charney, A. W. et al. Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder. Transl. Psychiatry 7, e993 (2017).","journal-title":"Transl. Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0242-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0242-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0242-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:29:30Z","timestamp":1671535770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-018-0242-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["242"],"URL":"https:\/\/doi.org\/10.1038\/s41398-018-0242-3","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,10]]},"assertion":[{"value":"26 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. McElroy is a consultant to or member of the scientific advisory boards of Bracket, F. Hoffmann-La Roche Ltd., MedAvante, Mitsubishi Tanabe Pharma America, Myriad, Novo Nordisk, Shire, and Sunovion. She is a principal or co-investigator on studies sponsored by the Allergan, Brainsway, Marriott Foundation, Myriad, National Institute of Mental Health, Novo Nordisk, Shire, and Sunovion. She is also an inventor on United States Patent No. 6,323,236 B2, Use of Sulfamate Derivatives for Treating Impulse Control Disorders, and along with the patent\u2019s assignee, University of Cincinnati, Cincinnati, Ohio, has received payments from Johnson & Johnson, which has exclusive rights under the patent. The other authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"188"}}